Regulatory roles for histone deacetylation in IL-1β-induced nitric oxide release in pancreatic β-cells

Journal of Cellular and Molecular Medicine

Volumn 12, Issue 5A, 2008, Pages 1571-1583

  Susick, L ^a   Veluthakal, R ^a   Suresh, M V ^a   Hadden, T ^b   Kowluru, A ^a,b  

^a WAYNE STATE UNIVERSITY   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

cell; Apoptosis; Histone deacetylases; Histones; INOS, PKC

Indexed keywords

ENZYME INHIBITOR; HISTONE; HISTONE DEACETYLASE; HYDROXAMIC ACID; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; NITRIC OXIDE; PROTEIN KINASE C DELTA; TRICHOSTATIN A;

ACETYLATION; ARTICLE; CELL LINE; CELL SURVIVAL; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PANCREAS ISLET BETA CELL; SECRETION; TIME;

ACETYLATION; CELL LINE; CELL SURVIVAL; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HISTONE DEACETYLASES; HISTONES; HYDROXAMIC ACIDS; INSULIN-SECRETING CELLS; INTERLEUKIN-1BETA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PROTEIN KINASE C-DELTA; TIME FACTORS;

EID: 54149099810     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2007.00171.x     Document Type: Article

References (51)

1. Lin HS, Hu CY, Chan HY, Liew YY, Huang H P, Lepescheux L, Bastianelli E, Baron R, Rawadi G, Clément-Lacroix P. Anti-rheumatic activities of histone deacetylase (HDAC) inhibitors in vivo in collagen-induced arthritis in rodents. Br J Pharmacol. 2007 150 : 862 72.
2. Huber LC, Brock M, Hemmatazad H, Giger OT, Moritz F, Trenkmann M, Distler JH, Gay RE, Kolling C, Moch H, Michel BA, Gay S, Distler O, Jüngel A. Histone deacetylase/acetylase activity in total syn-ovial tissue derived from rheumatoid arthritis and osteoarthritis patients. Arthritis Rheum. 2007 56 : 1087 93.
3. Garcia BA, Busby SA, Shabanowitz J, Hunt DF, Mishra N. Resetting the epigenetic histone code in the MRL-lpr/lpr mouse model of lupus by histone deacetylase inhibition. J Proteome Res. 2005 4 : 2032 42.
4. Gray SG, De Meyts P. Role of histone and transcription factor acetylation in diabetes pathogenesis. Diabetes Metab Res Rev. 2005 21 : 416 33.
5. Chakrabarti SK, Francis J, Ziesmann SM, Garmey JC, Mirmira RG. Covalent histone modifications underlie the developmental regulation of insulin gene transcription in pancreatic beta cells. J Biol Chem. 2003 278 : 17 23.
6. Mosley AL, Ozcan S. Glucose regulates insulin gene transcription by hyperacetylation of histone H4. J Biol Chem. 2003 278 : 19660 6.
7. Mosley AL, Ozcan S. The pancreatic duodenal homeobox-1 protein (Pdx-1) interacts with histone deacetylases Hdac-1 and Hdac-2 on low levels of glucose. J Biol Chem. 2004 279 : 54241 7.
8. Mosley AL, Corbett JA, Ozcan S. Glucose regulation of insulin gene expression requires the recruitment of p300 by the beta-cell-specific transcription factor Pdx-1. Mol Endocrinol. 2004 18 : 2279 90.
9. Bach JF. Insulin-dependent diabetes melli-tus as an autoimmune disease. Endocr Rev. 2004 15 : 516 42.
10. Eizirik DL, Mandrup-Poulsen M. A choice of death: the signal-transduction of immune-mediated β-cell apoptosis. Diabetologia. 2001 44 : 2115 33.
11. Mandrup-Poulsen T. The role of inter-leukin-1 in the pathogenesis of IDDM. Diabetologia. 1996 39 : 1005 29.
12. Rabinovitch A, Suarez-Pinzon WL. Cytokines and their role in pancreatic islet β-cell destruction and insulin-dependent diabetes mellitus. Biochem Pharmacol. 1998 55 : 1139 49.
13. Eizirik DL, Cagliero E, Björkluncl A, Welsh N. Interleukin-1 induces the expression of an isoform of nitric oxide synthase in insulin-producing cells, which is similar to that observed in activated macrophages. FEBS Lett. 1992 308 : 249 52.
14. Pieper CM, Roza AM, Henderson JD, Jr., Zhu YR, Lai CS. Spatial distribution and temporal onset of NF-κB activation and inducible nitric oxide synthase within pancreatic islets in the pre-diabetic stage of genetic, diabetic-prone BB rats: attenuation by drug intervention decreases inflammatory cell infiltration and incidence of diabetes. Inflamm Res. 2004 53 : 22 30.
15. Heimberg H, Heremans Y, Jobin C, Leemans R, Cardozo AK, Darville M, Eizirik DL. Inhibition of cytokine-induced NF-kappaB activation by adenovirus-medi-ated expression of a NF-kappaB super-repressor prevents beta-cell apoptosis. Diabetes. 2001 50 : 2219 24.
16. Baker MS, Chen X, Cao XC, Kaufman DB. Expression of a dominant negative inhibitor of NF-kappaB protects MIN6 beta-cells from cytokine-induced apoptosis. J Surg Res. 2001 97 : 117 22.
17. Flodstrom M, Welsh N, Eizirik DL. Cytokines activate the nuclear factor kappa B (NF-kappa B) and induce nitric oxide production in human pancreatic islets. FEBS Lett. 1996 385 : 4 6.
18. Veluthakal R, Jangati GR, Kowluru A. IL-1beta-induced iNOS expression, NO release and loss in metabolic cell viability are resistant to inhibitors of ceramide synthase and sphingomyelinase in INS 832/13 cells. JOP. 2006 7 : 593 601.
19. Yu Z, Kone BC. Targeted histone H4 acetylation via phosphoinositide 3-kinase- and p70s6-kinase-dependent pathways inhibits iNOS induction in mesangial cells. Am J Physiol Renal Physiol. 2006 290 : 496 502.
20. Yu Z, Zhang W, Kone BC. Histone deacetylases augment cytokine induction of the iNOS gene. J Am Soc Nephrol. 2002 13 : 2009 17.
21. Stempelj M, Kedinger M, Augenlicht L, Klampfer L. Essential role of the JAK/STAT1 signaling pathway in the expression of inducible nitric-oxide syn-thase in intestinal epithelial cells and its regulation by butyrate. J Biol Chem. 2007 282 : 9797 804.
22. Huang BH, Laban M, Leung CH, Lee L, Lee CK, Salto-Tellez M, Raju GC, Hooi SC. Inhibition of histone deacetylase 2 increases apoptosis and p21Cip1/WAF1 expression, independent of histone deacetylase 1. Cell Death Differ. 2005 12 : 395 404.
23. Larsen L, Tonnesen M, Ronn SG, Storling J, Jorgensen S, Mascagni P, Dinarello CA, Billestrup N, Mandrup-Poulsen T. Inhibition of histone deacetylases prevents cytokine-induced toxicity in beta cells. Diabetologia. 2007 50 : 779 89.
24. Carpenter L, Cordery D, Biden TJ. Protein kinase Cdelta activation by interleukin-1beta stabilizes inducible nitric-oxide syn-thase mRNA in pancreatic beta-cells. J Biol Chem. 2001 276 : 5368 74.
25. Veluthakal R, Chvyrkova I, Tannous M, McDonald P, Amin R, Hadden T, Thurmond DC, Quon MJ, Kowluru A. Essential role for membrane lipid rafts in interleukin-1beta-induced nitric oxide release from insulin-secreting cells: potential regulation by caveolin-1. Diabetes. 2005 54 : 2576 85.
26. Chen HQ, Tannous M, Veluthakal R, Amin R, Kowluru A. Novel roles for palmitoylation of Ras in IL-1 beta-induced nitric oxide release and caspase 3 activation in insulin-secreting beta cells. Biochem Pharmacol. 2003 66 : 1681 94.
27. Tannous M, Veluthakal R, Amin R, Kowluru A. IL-1beta-induced nitric oxide release from insulin-secreting beta-cells: further evidence for the involvement of GTP-binding proteins. Diabetes Metab. 2002 28 : 3S78 84.
28. Tannous M, Amin R, Popoff MR, Fiorentini C, Kowluru A. Positive modulation by Ras of interleukin-1beta-mediated nitric oxide generation in insulin-secreting clonal beta (HIT-T15) cells. Biochem Pharmacol. 2001 62 : 1459 68.
29. McDonald P, Veluthakal R, Kaur H, Kowluru A. Biologically active lipids promote trafficking and membrane association of Rac1 in insulin-secreting INS 832/13 cells. Am J Physiol Cell Physiol. 2007 292 : 1216 20.
30. Veluthakal R, Kaur H, Goalstone M, Kowluru A. Dominant-negative alpha-sub-unit of farnesyl- and geranyltransferase inhibits glucose-stimulated, but not KCl-stimulated, insulin secretion in INS 832/13 cells. Diabetes. 2007 56 : 204 10.
31. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 72 : 248 54.
32. Baradari V, Huether A, Hopfner M, Schuppan D, Scherubl H. Antiproliferative and proapoptotic effects of histone deacetylase inhibitors on gastrointestinal neuroendocrine tumor cells. Endocr Relat Cancer. 2006 13 : 1237 50.
33. Reddy RM, Yeow WS, Chua A, Nguyen DM, Baras A, Ziauddin MF, Shamimi-Noori SM, Maxhimer JB, Schrump DS, Nguyen DM. Rapid and profound potenti-ation of Apo2L/TRAIL-mediated cytotoxic-ity and apoptosis in thoracic cancer cells by the histone deacetylase inhibitor Trichostatin A: the essential role of the mitochondria-mediated caspase activation cascade. Apoptosis. 2007 12 : 55 71.
34. Taghiyev AF, Guseva NV, Glover RA, Rokhlin OW, Cohen MB. TSA-induced cell death in prostate cancer cell lines is cas-pase-2 dependent and involves the PIDDosome. Cancer Biol Ther. 2006 5 : 1199 205.
35. Camelo S, Iglesias AH, Hwang D, Due B, Ryu H, Smith K, Gray SG, Imitola J, Duran G, Assaf B, Langley B, Khoury SJ, Stephanopoulos G, De Girolami U, Ratan RR, Ferrante RJ, Dangond F. Trans -criptional therapy with the histone deacety-lase inhibitor trichostatin A ameliorates experimental autoimmune encephalo -myelitis. J Neuroimmunol. 2005 164 : 10 21.
36. Yuan LW, Soh JW, Weinstein IB. Inhibition of histone acetyltransferase function of p300 by PKCdelta. Biochim Biophys Acta. 2002 21 (1592 205 11.
37. Shen S, Yu S, Binek J, Chalimoniuk M, Zhang X, Lo SC, Hannink M, Wu J, Fritsche K, Donato R, Sun GY. Distinct signaling pathways for induction of type II NOS by IFNgamma and LPS in BV-2 microglial cells. Neurochem Int. 2005 47 : 298 307.
38. Min KJ, Pyo HK, Yang MS, Ji KA, Jou I, Joe EH. Gangliosides activate microglia via protein kinase C and NADPH oxidase. Glia. 2004 48 : 197 206.
39. Zhang Y, Sif S, Dewille J. The mouse C/EBPdelta gene promoter is regulated by STAT3 and Sp1 transcriptional activators, chromatin remodeling and c-Myc repression. J Cell Biochem. 2007 102 : 1256 70.
40. Yuan ZL, Guan YJ, Chatterjee D, Chin YE. Stat3 dimerization regulated by reversible acetylation of a single lysine residue. Science. 2005 307 : 269 73.
41. Wang R, Cherukuri P, Luo J. Activation of Stat3 sequence-specific DNA binding and transcription by p300/CREB-binding protein-mediated acetylation. J Biol Chem. 2005 280 : 11528 34.
42. Horion J, Gloire G, El Mjiyatl N, Quivy V, Vermeulen L, Vanden Berghe W, Haegeman G, Van Lint C, Piette J, Habraken Y. Histone deacetylase inhibitor trichostatin A sustains sodium pervana-date-induced NF-κB activation by delaying IκBα mRNA resynthesis: comparison with TNFα. J Biol Chem. 2007 282 : 15383 93.
43. Granja AG, Sablna P, Salas ML, Fresno M, Revilla Y. Regulation of inducible nitric oxide synthase expression by viral A238L-mediated inhibition of p65/RelA acetylation and p300 transactivation. J Virol. 2006 80 : 10487 96.
44. Hu J, Colburn NH. Histone deacetylase inhibition down-regulates cyclin D1 transcription by inhibiting nuclear factor-kappaB/p65 DNA binding. Mol Cancer Res. 2005 3 : 100 9.
45. Yamagoe S, Kanno T, Kanno Y, Sasaki S, Siegel RM, Lenardo MJ, Humphrey G, Wang Y, Nakatani Y, Howard BH, Ozato K. Interaction of histone acetylases and deacetylases in vivo. Mol Cell Biol. 2003 23 : 1025 33.
46. Blanco JC, Minucci S, Lu J, Yang XJ, Walker KK, Chen H, Evans RM, Nakatani Y, Ozato K. The histone acetylase PCAF is a nuclear receptor coactivator. Genes Dev. 1998 12 : 1638 51.
47. Wolffe AP. Transcriptional control. Sinful repression. Nature. 1997 387 : 16 7.
48. Van Lint C, Emiliani S, Verdin E. The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation. Gene Expr. 1996 5 : 245 53.
49. Yu Z, Zhang W, Kone BC. Signal transducers and activators of transcription 3 (STAT3) inhibits transcription of the inducible nitric oxide synthase gene by interacting with nuclear factor κB. Biochem J. 2002 367 : 97 105.
50. Wei J, Guo H, Gao C, Kuo PC. Peroxide-mediated chromatin remodelling of a nuclear factor kappa B site in the mouse inducible nitric oxide synthase promoter. Biochem J. 2004 377 : 809 18.
51. Soltoff SP. Rottlerin: an inappropriate and ineffective inhibitor of PKCδ. Trends Pharmacol Sci. 2007 28 : 453 8.